$HSAC News
Last published 6y ago
- 6y agoIMVTHSACImmunovant Sciences Ltd. Closes Transaction with Health Sciences Acquisitions CorporationGlobeNewswireNEW YORK, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Immunovant, Inc., (Nasdaq: IMVT) formerly known as Health Sciences Acquisitions Corporation (Nasdaq: HSAC) (“HSAC”), a special purpose acquisition company...
- 7y agoHSACHealth Sciences Acquisitions Corporation and Immunovant to Host Joint Conference Call for the Investment Community on Friday, October 11, at 8:30am EDTPR NewswireHealth Sciences Acquisitions Corporation ("HSAC," NASDAQ: HSAC), a special purpose acquisition company sponsored by RTW Investments, and Immunovant...
- 7y agoHSACCHACChardan Advises Health Sciences Acquisitions Corporation on Merger with ImmunovantPR NewswireChardan, a global investment bank, announced today that the firm acted as M&A and Capital Markets Advisor for Health Sciences Acquisitions...
- 7y agoHSACImmunovant to Merge with Health Sciences Acquisitions Corporation, Creating New Publicly Listed FcRn-Focused CompanyPR NewswireHealth Sciences Acquisitions Corporation ("HSAC," NASDAQ: HSAC), a special purpose acquisition company sponsored by RTW Investments, and Immunovant...